Partnering opportunities

Biomarker companies looking to collaborate

Business and academia from UK and around the world looking to partner to co-develop biomarker technology. We can connect you.

We help ambitious, post-start up businesses, to

  • Move into new markets
  • Access funding
  • Use our networks
  • Innovate to grow
  • Find trusted partners
Innovate UK
HM Government
European Commission

Start new search
Refine

5 total opportunities

Filter your results

I’m looking for a partner...
Country of origin

{[{ data.total | number }]} opportunities

5 opportunities

Get updates to this list

The search results below each have a summary which you may find useful in determining if the opportunity is what you’re looking for.

{[{ row.title }]}

{[{ row.summary }]}

Country of origin {[{ row.country }]}

First biomarker test for the diagnosis of osteoarthritis

-4 in order to strengthen significance of diagnosis (Table 1). Thus the present invention is the first serum biomarker test that helps to support the clinical diagnosis of OA. The university offers a license... more

Germany

Urinary marker for bladder cancer detection

recurrence rate patients require regular follow-up examinations, currently done by cystoscopy. The new biomarker developed at a Bavarian Research Institute is based on the focal adhesion protein LIM and SH3 (LASP)-1... more

Germany

Peptide for cancer control linked to IL13Rα2 overexpression

ovarian, where it has been proposed as biomarker and potential therapeutic target. There is a need for improved strategies for treating tumors and other diseases where IL13Rα2 is expressed, like glioblastoma... more

Spain

Urinary marker for bladder cancer detection

recurrence rate patients require regular follow-up examinations, currently done by cystoscopy. The new biomarker developed at a Bavarian Research Institute is based on the focal adhesion protein LIM and SH3 (LASP)-1... more

Germany

Early classification of aggressive prostate cancers

is a correlation with the risk for metastasis and the Gleason score, however there is an ongoing search for new biomarkers that directly correlate with the risk for metastasis. A German university discovered vimentin 3 (Vim3) as biomarker more

Germany

The right partner not here?

Get in touch and we'll help you post a partnering opportunity

Hash